Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacogenomically Selected Treatment for Gastric and GEJ Tumors
NCT00515216Phase 2Completed
- Sponsor
- Vanderbilt University
- Start
- Aug 2007
- Primary completion
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fluorouracil in gastric cancer (GC), gastroesophageal junction adenocarcinoma, sponsored by Vanderbilt University. Started Aug 2007; status: completed.
02
Drugs
fluorouracil
03
Conditions
gastric cancer (GC)gastroesophageal junction adenocarcinoma
Beyond the preview
Go deeper on NCT00515216.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00515216.